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Upon insult, such as infection or tissue injury, the
innate and adaptive immune systems initiate a series
of responses to defend the body. Recent studies from
immune cell-specific androgen receptor (AR) knock-
out mice demonstrated that androgen and its receptor
(androgen/AR) play significant roles in both immune
regulations. In the innate immunity, androgen/AR is
required for generation and proper function of neu-
trophils; androgen/AR also regulates wound healing
processes through macrophage recruitment and pro-
inflammatory cytokine production. In adaptive im-
munity, androgen/AR exerts suppressive effects on
development and activation of T and B cells. Removal
of such suppression causes thymic enlargement and
excessive export of immature B cells. Altogether,
androgen/AR plays distinct roles in individual im-
mune cells, and targeting androgen/AR may help in
treatment and management of immune-related
diseases. (Am J Pathol 2012, 181:1504–1512; http://dx.doi.
org/10.1016/j.ajpath.2012.07.008)
The immune system includes both innate and adaptive
immune responses. Once insult to the body (eg, infec-
tion) is initially encountered, the innate system acts within
minutes, followed some hours later by early induced re-
sponses conducted by recruited effector cells, such as
1504neutrophils and macrophages, in a nonspecific man-
ner.1,2 In most cases, infections are eliminated by the
innate immune system. When pathogens breach the first
line of immune defense, however, the adaptive immune
system is activated with antigen-specific effectors (eg, T
and B cells), and the generation of memory cells ensures
a long-lasting and prompt response to recurrent infection
with the same pathogens. On the other hand, the context
of the activated innate immunity also shapes the outcome
of adaptive immune responses.3
Androgen and androgen receptor (AR) signals control
the development and function of both male and female
reproductive systems.4–6 The AR gene is located on the
X chromosome in both the human and the murine ge-
nome. AR is a prototypical nuclear receptor, containing
an N-terminal domain, a ligand-binding domain, a DNA-
binding domain, and a C-terminal domain.7 After binding
of its ligands, testosterone or 5-dihydrotestosterone, AR
translocates into the nucleus and binds to androgen re-
sponsive elements on the promoters or enhancers of
target genes, thereby turning on their expression.8 The
expression of AR has been detected in various immune
cell lineages, including neutrophils, mast cells, macro-
phages, B cells, and T cells,9–11 implying the involvement
of androgen and its receptor (androgen/AR) in regulating
the development and function of the immune system.
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humans, the male sex hormones may modulate the de-
velopment and function of the immune system. Males are
at higher risk of developing sepsis, acute respiratory
distress, and multiorgan failure after soft-tissue traumatic
hemorrhagic shock and thermal injury, in part because of
immune suppression and abnormal activation of neutro-
phils.12 On the other hand, males are less prone to au-
toimmune diseases. Of more than 70 chronic disorders
categorized as autoimmune diseases, many affect pre-
dominantly women.13,14 Various studies have uncovered
important immune regulatory functions of androgen/AR
(as discussed below), and such nonclassical roles of
androgen/AR outside the reproductive system are impor-
tant for understanding the pathogenesis of these immu-
nological conditions.
Recent studies using conditional AR knockout (ARKO)
mice, with knockout of AR in selective immune cells,
opened a new era for investigating the nonclassical roles
of androgen/AR involved in immune regulation; these
studies also suggest potential for the development of new
therapeutic strategies for treating immune-related dis-
eases.6,15 In this review, we summarize the roles of an-
drogen/AR in both the innate and adaptive components
of the immune system (specifically neutrophils, macro-
phages, T cells, and B cells), as well as new evidence
from studies using conditional ARKO mice. We also ad-
dress the potential influences of androgen/AR on im-
mune-related diseases.
Androgen/AR in the Innate Immune System
Roles of Neutrophil AR in Defending the Body
Granulopoiesis is a dynamic process leading to the pro-
duction of 120 billion granulocytes daily in humans; its
synthesis capacity can be increased at least 10-fold in
response to certain stress conditions, including infection.
Neutrophils are the most abundant type of granulocyte;
eosinophils and basophils are much rarer. Upon insult,
neutrophils arrive on site within minutes and usually peak
at 12 to 24 hours, establishing the first line of immune
defense. In addition to their major function for the phago-
cytosis of invading infections/pathogens or damaged tis-
sues, neutrophils are able to secrete several chemokines
and cytokines to attract and activate monocytes/macro-
phages.16,17
Originating from hematopoietic stem cells and progen-
itors, neutrophils in the bone marrow are composed of a
precursor pool and a storage pool. Peripheral blood neu-
trophils, which are postmitotic, consist of a free circulat-
ing pool and a marginal pool. AR is universally expressed
in neutrophil lineages from the proliferative precursors
(myeloblasts, promyelocytes, and myelocytes) to mature
neutrophils (metamyelocytes, band forms, and neutro-
phils), with no difference in AR expression patterns be-
tween males and females.10 Both band and segmented
neutrophils express high levels of nuclear and cytoplas-
mic AR.10 In myelocytes, AR is stained positively in the
cytoplasm and shows perinuclear dot staining. Similarly,AR is localized in the cytoplasm of myeloblasts, but with-
out perinuclear dot staining.10 Young women who suffer
from polycystic ovarian syndrome with hyperandro-
genism have higher neutrophil counts, which can be nor-
malized by treatment with the antiandrogen flutamide,
suggesting that androgen/AR signals can promote neu-
trophil production.18
Consistent with this notion, we found almost 90% re-
duction of neutrophil counts in general ARKO (G-ARKO)
mice, compared with wild-type mice, and a similar reduc-
tion was also found in male mice carrying the testicular
feminization (Tfm) mutation in the AR gene.19 Tfm is a
natural single nucleotide deletion mutation at the first
exon of the AR gene that results in expression of unstable
AR transcripts.20,21 Castration of male mice also resulted
in neutrophil reduction; however, the effect of castration
was less dramatic than in ARKO or Tfm mice. These
results suggest that AR confers a direct and more pro-
found effect than androgen to control neutrophil produc-
tion. Although neutropenia was observed in some pros-
tate cancer patients treated with antiandrogens,22,23
castration in humans does not always result in neutrope-
nia but may instead lead to only a mild reduction of
neutrophil counts, suggesting that AR, but not andro-
gen, is more critical for neutrophil homeostasis.19 Fur-
ther analysis of neutrophil lineages showed that myelo-
cytes/metamyelocytes and mature neutrophils, but not
myeloblasts and promyelocytes, were significantly re-
duced in ARKO mice. Additionally, restoring the AR
expression in the ARKO granulocyte-macrophage pro-
genitors rescued neutrophil production, implying that
AR is essential in regulating neutrophil differentia-
tion.19 Further studies also suggested that AR regu-
lates primarily the transition between proliferation of
precursors (myeloblasts, promyelocytes, and myelo-
cytes) and maturation of neutrophils (metamyelocytes,
band forms, and neutrophils).19
Mechanistically, AR appears to stimulate neutrophil
production by enhancing granulocyte colony-stimulating
factor (G-CSF) signaling. This is achieved by activating
ERK1/2 and also by sustaining Stat3 activity via diminish-
ing the inhibitory binding of protein inhibitor of activated
STAT protein 3 (PIAS3).19 Such AR-PIAS3 interaction
does not rely on ligand binding, and could be considered
an androgen-independent regulation. Notably, the major
induction of Stat3 reporter activity was caused by AR
expression and was only slightly enhanced by adding an-
drogens, suggesting that androgens are not essential for
the function of AR in promoting Stat3 activity.19 Other lines
of evidence using in vitro and transgenic mouse studies
have demonstrated that Stat3 plays an essential role in
G-CSF-dependent granulopoiesis.24–26 Moreover, several
reports have shown that mice with knockout of suppressor
of cytokine signaling 3 (SOCS-3), in which Stat3 activity is
persistent, developed severe neutrophilia.27–29
Neutrophils are a key component of the innate immune
system in clearing bacterial pathogen infection. As a
result of neutrophil reduction, the ability of ARKO mice to
survive pathogenic bacteria challenge is severely com-
promised.19 In addition to reduced neutrophil counts,
functional defects of neutrophils also contributed to the
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Although the residual neutrophils in ARKO mice retained
the normal capacity for phagocytosis and respiratory
burst, they produced less proinflammatory cytokines IL-
1, IL-6, and TNF- and of chemokines CCL2, CCL3,
CCL4, CXCL1, CXCL4, and CXCL7.19
It has long been suspected that chronic inflammation
can promote prostate tumorigenesis and progression.
Several lines of evidence show that mice lacking proin-
flammatory cytokines are resistant to carcinogenesis, tu-
mor invasion, and angiogenesis.30,31 Because it is impor-
tant for sustaining proinflammatory cytokine expression
(TNF-, IL-1, IL-6) in neutrophils and macrophages,19,32
AR may play a pivotal role in remodeling the tumor-
promoting microenvironment via release of proinflamma-
tory cytokines from neutrophils.
Neutrophils can be attracted by IL-8 released from
castration-resistant prostate cancer cells; they then mi-
grate toward the tumor lesion and release enzymes (eg,
MMP-9, collagenase) to remodel the extracellular matrix
of nearby tissues.33 Thus, neutrophils could serve as
enhancers of cancer cell migration through remodeling of
the extracellular matrix. Moreover, the reactive oxygen
species produced by neutrophilic oxidases to kill invad-
ing organisms have the potential to interact with tumor
cells, attenuating their apoptotic cascade and increasing
their mutation rate and malignancy.33
Roles of Macrophage AR in Regulating
Inflammatory Responses
Immediately after neutrophil activation, monocytes are
recruited from the circulation into inflamed tissues in re-
sponse to chemokines secreted from neutrophils and
damaged tissues.34 The infiltrated monocytes subse-
quently differentiate into macrophages, which in turn be-
come the master regulators of the inflammatory re-
sponse. The hallmark functions of macrophages include
not only phagocytosis of the infecting microbes, dead
neutrophils, and tissue debris, but also the production of
proinflammatory cytokines and growth factors to regulate
the succeeding immune responses and tissue regener-
ation.17,35 In addition, macrophages can present anti-
gens to T cells, and thus macrophage activity shapes the
successive T cell activation and bridges innate immunity
and the adaptive immune response. Increasing evide-
nce shows that macrophages play an important role in
regulating tissue regeneration and inflammatory respon-
ses during wound healing and traumatic-hemorrhagic
shock.36 Interestingly, AR expression has been detected
in the monocyte/macrophage population,37 suggesting
that AR might modulate macrophage functions involved
in these inflammatory conditions.
Macrophage AR Promotes Inflammation in
Cutaneous Wound Healing
In the early phase of cutaneous wound healing, macro-
phages are among the major inflammatory cells recruitedto the injured tissues. Although inflammation is necessary
for removing tissue debris, an excess of it hinders wound
healing.36,38 Castration of animals or blockade of andro-
gen action by antiandrogen (flutamide) accelerated
wound healing and suppressed macrophage recruitment
to the wounds.37,39 In a mouse model of wound healing,
the proinflammatory cytokine TNF-, but not IL-6, at the
site of injury was down-regulated by castration or flut-
amide treatment. Conversely, in vitro studies found that
lipopolysaccharide-induced TNF- production in macro-
phages was enhanced by testosterone treatment.37
These data suggest that androgens might regulate in-
flammatory responses to suppress wound healing.
Notably, increasing evidence from in vitro studies
shows that androgens can also go through non-AR
pathways to regulate cellular activities,40,41 and there-
fore using castration or antiandrogens to decrease an-
drogen levels cannot clarify whether the androgen ef-
fects are through AR or non-AR pathways to inhibit
wound healing.
Interestingly, a recent report using the Cre-loxP sys-
tem to generate conditional ARKO mice found that
mice lacking AR had accelerated wound healing, and
such acceleration could not be reversed by 5-dihy-
drotestosterone restoration, suggesting that AR sig-
nals, rather than androgen itself, are critical to sup-
pression of wound healing.32 Using reciprocal bone
marrow transplantation, it was found that AR deficiency
in the infiltrating cells, and not in mesenchymal cells,
was responsible for the accelerated wound healing in
ARKO mice. AR in the wild-type donor bone marrow
cells, even in the low-testosterone environment of
ARKO recipients, could still suppress wound healing,
suggesting that AR can go through androgen-indepen-
dent pathways to suppress wound healing.32 Although
the detailed mechanisms of these androgen-indepen-
dent AR effects in wound healing remain unclear, these
results are in accord with earlier studies showing that
AR could also be activated by other factors in addition
to androgens, such as estrogens,42 antiandrogens,43
and kinases.44,45 Similarly, as already noted, AR might
go through androgen-independent signals to promote
neutrophil differentiation.19 Further studies are war-
ranted, to determine whether any of these mechanisms
are involved in suppression of wound healing. Taken
together, these studies reveal the novel concept that
AR, but not androgen, is critical for wound healing
suppression.
The essential roles of monocyte/macrophage AR in
wound healing suppression were further corroborated in
a study using myeloid-specific ARKO mice (M-ARKO),
which found that AR in the infiltrating monocytes/macro-
phages executed its suppressive roles in cutaneous
wound healing by enhancing local TNF- expression via
the following mechanisms: i) increasing circulating in-
flammatory monocyte population, ii) increasing recruit-
ment of monocytes by promoting their chemotaxis
through up-regulation of CCR2 expression, and iii) in-
creasing TNF- expression at the transcriptional level in
macrophages.32 Although the results from bone marrow
transplantation imply androgen-independent AR func-
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that the AR regulation of TNF- and CCR2 expression is
androgen-dependent and directly regulates the promoter
activities of these two proteins.32
These findings demonstrate the essential roles of AR in
the macrophage-associated inflammatory regulation to-
ward the pathological conditions (such as wound heal-
ing) and raise an important question, whether monocyte/
macrophage AR may also play essential roles in other
inflammatory diseases that demonstrate sex differences,
such as atherosclerosis46 and asthma.47 A positive an-
swer may then point toward development of a potential
therapeutic approach via targeting AR in treatment and
management of these sexually dimorphic inflammatory
diseases.
Role of Androgen/AR Signals in the Adaptive
Immune System
Unlike macrophages and neutrophils, which play a cen-
tral role in the innate immune system,48 T and B cells
represent the central players in adaptive immune re-
sponse. The activation of T and B cells requires proper
antigen presentation, cell-cell interaction (engagement of
T cell receptor TCR, or B cell receptor BCR, and costimu-
lation), and specific environmental cytokine profiles.
Studies using castration and Tfm mouse models suggest
that androgen/AR signals are involved in both differenti-
ation and activation of T cells and B cells, and might
contribute to the sexual dimorphism of autoimmune dis-
eases.21
Role of Androgen/AR in the Development and
Activation of T Cells
Androgen/AR Signals in T Cell Development
The thymus is the major organ in which naïve T cells
develop. Several studies have shown that T cell generation
from thymus is significantly reduced after puberty,49,50 sug-
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single-positive T cells.54–56 Although neonatal castration
in a rat model led to increased incidence of autoimmune
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cytes. The aforementioned reduction of thymocyte apop-
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there is no role for androgen/AR signals in enhancing
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sion in CD3lowCD8 immature thymocytes.61 AR expres-
sion in the thymic stroma was also demonstrated.53 Within
the thymic stroma, AR is expressed predominantly in the
cortical and medullar thymic epithelial cells.53
Reciprocal bone marrow transplantation between nor-
mal male mice and Tfm male mice was used to determine
whether AR expression in thymocytes or thymic epithelial
cells is important for androgen/AR effects on thymic de-
velopment. Bone-marrow chimeric mice with bone mar-
row grafts from Tfm mice to normal mice showed normal
response to androgen and thymic involution. In contrast,
chimeric mice receiving bone marrow from normal mice
to Tfm mice developed enlarged thymus and were insen-
sitive to androgen.53 These findings, together with the
evidence for AR expression in thymic stroma, suggest
that AR expression in thymic stroma, rather than thymo-
cytes, is responsible for inhibition of T cell development
by androgen/AR signals. Using G-ARKO mice, we have
performed similar bone marrow chimeric studies and
confirmed the importance of AR expression in thymic
stroma (Lai et al, unpublished data).
Based on the residing compartment, thymic epithelial
cells can be further divided into cortical thymic epithelial
cells (cTECs) and medullar thymic epithelial cells
(mTECs). These two populations have distinct functions
in thymocyte development.62 cTECs play a crucial role in
positive selection.63 After positive selection, the double-
positive thymocytes encounter other stromal cells (in-
cluding macrophages, dendritic cells, and mTECs) in the
medullar compartment for negative selection. The role of
mTECs in central tolerance has been of great interest
since the discovery of promiscuous expression of tissue-
restricted self-antigens in these cells.64 Thus, mTECs can
directly induce or, through cross-presentation of self-an-
Table 1. Immune-Related Phenotypes in Tissue-Specific ARKO M
Characteristic Castration
Mutation/Cre promoter Natural A
AR mR
Specific tissue/cell Systemic androgen
level decreased
General
Phenotype
T-cell development Thymus enlargement Thymus e
B-cell development/
function
Increased immature
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Immature
popula
Neutrophil development/
function
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of neutrophil
counts
Neutrope
Wound healing Accelerated
cutaneous wound
healing
NA
Related human disease Autoimmune
disease; wound
healing
Autoimmu
septice
healing
The mice from castration treatment, Tfm mutation, G-ARKO, T-ARK
comparison. Also included is usage of specific Cre promoter, deficiency of AR i
NA, not applicable.tigens, promote negative selection of self-reactive T cells.
We have established TEC-ARKO mice by using bovine
keratin-5 promoter Cre to delete AR in thymic epithelial
cells and found that AR was ablated in both cTEC and
mTEC populations (Lai et al, unpublished data). Upon
further breeding of ARKO with TCR transgenic mice, re-
sults suggested that AR plays an essential role in regu-
lating positive selection. In contrast to TEC-ARKO mice, T
cell–specific ARKO (T-ARKO) mice with AR deletion in
thymocytes revealed normal size and cellularity of thy-
mus (Lai et al, unpublished data). These results are in
accord with findings in bone marrow transplantations
showing that AR in thymic epithelial cells plays a more
crucial role than thymocytes in thymic development.
To investigate the potential targets of androgen/AR in
thymocyte development, we demonstrated that ARKO
thymic stromal cells expressed less mRNA of TGF1,
IL-6, and CD80/CD86, but more of IL-7 and CCL21, com-
pared with wild-type thymic stromal cells on 5-dihy-
drotestosterone treatment (Lai et al, unpublished data).
Interestingly, androgen/AR can up-regulate CD80 pro-
moter activity through direct promoter binding (Lai et al,
unpublished data). Notably, it has been shown that in
CD28 or B7 (CD80/CD86) knockout mice, the selection of
mature CD4 and CD8 single-positive thymocytes was
increased,65 suggesting that CD28-B7 engagement
serves as a negative regulator for positive selection. This
may explain, at least in part, how androgen/AR signaling
inhibits positive selection of thymocytes.
Effect of Androgen/AR on Peripheral T Cell Function
In addition to effects in development, the effect of
androgen/AR on T cell–mediated immune responses has
been recognized in many models of cellular immunity.
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AJP November 2012, Vol. 181, No. 5Administration of androgens to female mice alleviated
rejection of skin grafts and alleviated CD4 T cell–medi-
ated autoimmune diseases such as experimental autoim-
mune encephalomyelitis, whereas castration in male
mice exacerbated this autoimmune disease.66–68 The
effects of androgen/AR on peripheral T cell response are
twofold: first, androgen/AR suppresses T cell prolifera-
tion; second, androgen/AR modulates the balance of Th1
and Th2 responses. In terms of T cell proliferation, T cells
from castrated mice proliferated more vigorously in vitro
than T cells from normal mice regardless of the modes of
T cell activation, although the effect seemed to be tran-
sient.55 Because the enhancement of T cell activation
could occur in the absence of antigen-presenting cells or
any other accessory cells, androgen/AR appeared to ex-
ert a direct effect on T cells. This is an issue of debate,
however, given that some studies have found no AR
expression in peripheral T cells,21 whereas others have
shown weak expression of AR mRNA in peripheral T
cells.69 In models of burn injury and hemorrhagic shock
in which delayed-type hyper-responsiveness and T cell
proliferation were suppressed, blockade of androgen/AR
restored T cell response, which was accompanied by
increased IL-2 production and IL-2R expression in T
cells.70,71 Thus, androgen/AR appears to suppress T cell
proliferation by diminishing IL-2 signaling in T cells.
Regulation of Th1 and Th2 Responses by Androgen/AR
The inhibitory action of androgen/AR on T cell prolifera-
tion may be a contributing factor for the lower incidence of
autoimmune diseases in males than in females. In addition,
evidence has accumulated to support a role of andro-
gen/AR in regulating the functional differentiation of periph-
eral CD4 T cells, which may have even greater im-
Table 1. Continued
B-ARKO M-ARKO
CD19 promoter Lysozyme M promoter
B cell Myeloid cell
NA NA
Immature B-cell population
increased; autoantibodies
increased
NA
NA Normal granulopoiesis in bon
marrow; moderate reductio
of neutrophil counts in
circulation
NA Accelerated cutaneous woun
healing
Autoimmune disease Wound healingplications for the sexual dimorphism of autoimmunity.
Organ-specific autoimmune diseases such as experimen-
tal autoimmune encephalomyelitis are typically associated
with biased Th1 immune responses to autoantigens. In a
study using experimental autoimmune encephalomyelitis,
autoantigen-specific T cells from immunized male animals
were less capable of transferring disease, compared with T
cells from female animals.69 Analyses of cytokine profiles of
the autoreactive T cells showed higher IFN- production in
female than inmalemice. In in vitro cultures, the presence of
androgen diminished both the differentiation of Th1 cells
from naïve precursors and the production of IFN- by T-
helper effector cells induced by TCR stimulation.69 Andro-
gen treatment also decreased IL-12–induced IFN- pro-
duction by CD4 T cells through inhibition of Stat4
activation.72 Although the study was performed on resting
CD4 T cells that were previously activated by concanavalin
A, one may extrapolate a role of androgen-mediated inhibi-
tion of Stat4 activation in dampening Th1 differentiation from
naïve CD4 T cells as well, because IL-12 is a potent inducer
of Th1 cell differentiation.73
Finally, it should be pointed out that the Th1 and Th2
divergence of immune response between males and fe-
males is not restricted to autoimmunity. It was also ob-
served in hemorrhagic shock that androgen/AR sup-
pressed IFN- and IL-2 expression by splenocytes in
male mice, whereas female mice maintained strong pro-
duction of these two cytokines.74
Role of Androgen/AR Signals in the
Development and Activation of B Cells
The major function of B cells is to produce antibodies on
stimulation. Most of the B cells respond to foreign anti-
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A NA
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AJP November 2012, Vol. 181, No. 5gens, such as virus, bacteria, and toxins; however, some
autoreactive B cells escape from negative selection dur-
ing B-cell development and are released into the periph-
ery. These autoreactive B cells are able to produce anti-
bodies against self antigens and subsequently result in
autoimmunity and in autoimmune diseases, such as sys-
temic lupus erythematosus and rheumatoid arthritis, and
therefore B cells have been one of the primary targets for
autoimmune therapy.75 Moreover, profound sexual di-
morphism in autoimmune diseases implies that sex hor-
mones might involve the regulation of B-cell responses
and/or their development.76
B-cell development is negatively regulated by andro-
gen/AR. Castration of male mice caused splenic enlarge-
ment, due primarily to the increase of B cells.52,61 Further
studies found that B cells were increased not only in the
spleen but also in the bone marrow of castrated mice.
The B cell increase could occur in thymectomized mice,
and therefore it was independent of the effect of castra-
tion on T cells.9 Similar increases of B cells in bone
marrow and spleen were also observed in Tfm mice.77
Closer examination of the B-cell lineage in the bone mar-
row of castrated mice revealed the most dramatic in-
crease in the late pro-B population, and to lesser degrees
in the pre-B- and immature B-cell populations.78 The
increase of B-cell progenitors in the bone marrow led to
the increase of the peripheral B-cell pool, with altered
composition. Specifically, the proportion of newly emi-
grated immature B cells was found to be up to 45% of
total circulating B cells in castrated and Tfm mice,
although these cells represent only 10% to 15% in
normal mice.77,78
Both bone marrow stroma and B cells express AR,10
and both cell types could be the targets of androgen/AR
in regulating B-cell lymphopoiesis. In bone marrow chi-
meric studies between Tfm and normal mice, the expres-
sion of intact AR on bone marrow stroma was critical for
the inhibition of B-cell lymphopoiesis by androgen/AR.79
On the other hand, mice with either general or B cell–
specific knockout of the AR gene showed enhanced B-
cell lymphopoiesis, demonstrating that B cells are direct
targets of androgen.15 However, the B cell–specific
ARKO mice, showed a milder effect on B-cell lymphopoi-
esis, compared with the general ARKO mice. The full
effect of androgen on B-cell lymphopoiesis therefore de-
pends on its action on both B cells and the stroma. In
both the general and the B cell–specific ARKO mice, the
pre-B- and immature B-cell populations were increased
in the bone marrow, apparently due to both increased
proliferation and reduced apoptosis.15 Mechanistically,
the expression of several key proapoptotic molecules,
such as Fas/FasL and caspase-3/8, were reduced in
ARKO B cells.15 In contrast, elevated cell proliferation
was observed in ARKO B cells, accompanied by up-
regulation of p65 and Bcl-2 expression.15 These findings
came mainly from primary culture of immature B cells
cultured in a medium (MesenCult) containing very low
levels of androgen. The above-mentioned changes in
gene expression could therefore be due primarily to an-
drogen-independent pathways, although androgen-de-pendent regulation could not be completely ruled out in
this study.15
The enlarged B-cell pool could potentially increase the
frequency of autoreactive B cells in castrated or AR de-
ficient mice. In fact, in both the general and the B cell–
specific ARKO mice, levels of anti–double-stranded DNA
antibodies were significantly elevated.15 Thus, removal of
the brake on B-cell lymphopoiesis imposed by andro-
gen/AR could lead to autoimmune diseases in which
autoantibodies play pathogenic roles. Examples of such
consequences could be found in hypogonadal men with
rheumatoid arthritis and/or systemic lupus erythemato-
sus80,81 and in prostate cancer patients who received
androgen ablation therapy and subsequently developed
rheumatoid arthritis at higher rates.82 Conversely, andro-
gen replacement therapy of hypogonadal men with rheu-
matoid arthritis ameliorated clinical symptoms and re-
duced the concentrations of IgM rheumatoid factors.
Concluding Remarks
The study of immune regulation by androgen/AR has
attracted long-lasting interest. The recent availability of
cell lineage-specific ARKO mice has opened new ave-
nues of research.6,15,19,32 Up-to-date studies using these
animal models and other approaches have shown that
androgen/AR exerts different regulatory effects on the im-
mune system, which may also be influenced by the patho-
physiological conditions of the hosts (Figure 1; Table 1). For
neutrophils, androgen/AR plays a positive role for both
development and function. These effects appear to be
beneficial for hosts, to survive bacterial challenge.19 Al-
though androgen/AR enhances proinflammatory cytokine
production by macrophages in wound healing,32 it inhib-
its cytokine production after traumatic-hemorrhagic
shock and burns. For the adaptive arm of the immune
system, androgen/AR has generally inhibitory effects on
T- and B-cell development. In the periphery, andro-
gen/AR dampens T cell activation and inhibits Th1 differ-
entiation. These inhibitory effects of androgen/AR on B
and T cells may help lower the risk of autoimmunity in
males.15
Further studies applying these valuable mouse models
could not only advance our knowledge and understand-
ing of the communication between androgen/AR and the
immune system, but could also suggest novel strategies
to modulate the immune system under clinical conditions
in which regulation of immune responses by andro-
gen/AR plays critical roles.
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